225 related articles for article (PubMed ID: 15517700)
21. [Combined treatment in recurrent laryngeal papillomatosis with CO2 laser microlaryngoscopic resection and interferon alpha 2b].
Montero Mora P; Hernández Colín DD; Enríquez Palomec O; Mejía Ortega J
Rev Alerg Mex; 1996; 43(5):133-6. PubMed ID: 9005006
[TBL] [Abstract][Full Text] [Related]
22. Topical interferon alpha-2b as an adjunctive therapy in recurrent conjunctival papilloma.
Muralidhar R; Sudan R; Bajaj MS; Sharma V
Int Ophthalmol; 2009 Feb; 29(1):61-2. PubMed ID: 18000647
[No Abstract] [Full Text] [Related]
23. Recurrent respiratory papillomatosis: a 10 year study.
Benjamin B; Parsons DS
J Laryngol Otol; 1988 Nov; 102(11):1022-8. PubMed ID: 3209936
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
25. [Viferon treatment of recurrent respiratory papillomatosis in children].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Maslov IV; Tikhonenkova LP; Shchepin NV; Kol'tsov VD
Vestn Otorinolaringol; 2001; (5):47-9. PubMed ID: 11699097
[No Abstract] [Full Text] [Related]
26. [Efficacy of local use of recombinant interferon alpha-2 preparations in combined treatment of recurrent respiratory papillomatosis].
Pluzhnikov MS; Katinas EB; Riabova MA; Karpishchenko SA; Totolian AA
Vestn Otorinolaringol; 2008; (4):57-61. PubMed ID: 18833124
[TBL] [Abstract][Full Text] [Related]
27. Quality-of-life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patients.
Rataj D; Jankowiak B; Krajewska-Kułak E; Van Damme-Ostapowicz K; Nowecki ZI; Rutkowski P; Niczyporuk W
Cancer Nurs; 2005; 28(3):172-8. PubMed ID: 15915059
[TBL] [Abstract][Full Text] [Related]
28. Patient preferences for adjuvant interferon alfa-2b treatment.
Kilbridge KL; Weeks JC; Sober AJ; Haluska FG; Slingluff CL; Atkins MB; Sock DE; Kirkwood JM; Nease RF
J Clin Oncol; 2001 Feb; 19(3):812-23. PubMed ID: 11157035
[TBL] [Abstract][Full Text] [Related]
29. Phase I study of pegylated interferon-alpha-2b as an adjuvant therapy in Japanese patients with malignant melanoma.
Yamazaki N; Uhara H; Wada H; Matsuda K; Yamamoto K; Shimamoto T; Kiyohara Y
J Dermatol; 2016 Oct; 43(10):1146-1153. PubMed ID: 27087489
[TBL] [Abstract][Full Text] [Related]
30. Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
Hansson J; Aamdal S; Bastholt L; Brandberg Y; Hernberg M; Nilsson B; Stierner U; von der Maase H;
Lancet Oncol; 2011 Feb; 12(2):144-52. PubMed ID: 21256809
[TBL] [Abstract][Full Text] [Related]
31. [Cidofovir activity in infantile recurrent respiratory papillomatosis].
Palomar Asenjo V; Palomar García V; Soteras Ollé J; Ruiz Giner A
Acta Otorrinolaringol Esp; 2005 Jan; 56(1):22-4. PubMed ID: 15747720
[TBL] [Abstract][Full Text] [Related]
32. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis.
Leventhal BG; Kashima HK; Weck PW; Mounts P; Whisnant JK; Clark KL; Cohen S; Dedo HH; Donovan DJ; Fearon BW
Arch Otolaryngol Head Neck Surg; 1988 Oct; 114(10):1163-9. PubMed ID: 3046638
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James AL
Cochrane Database Syst Rev; 2005 Oct; (4):CD005053. PubMed ID: 16235390
[TBL] [Abstract][Full Text] [Related]
34. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
[TBL] [Abstract][Full Text] [Related]
35. Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice.
Ravaud A; Bedane C; Geoffrois L; Lesimple T; Delaunay M
Br J Cancer; 1999 Aug; 80(11):1767-9. PubMed ID: 10468294
[TBL] [Abstract][Full Text] [Related]
36. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan.
Hsu HY; Tsai HY; Wu TC; Chiang CL; Ni YH; Chen PJ; Chang MH
Liver Int; 2008 Nov; 28(9):1288-97. PubMed ID: 18397229
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of escalating doses of intravesical interferon alpha-2b in reducing recurrence rate and progression in superficial transitional cell carcinoma.
Giannakopoulos S; Gekas A; Alivizatos G; Sofras F; Becopoulos T; Dimopoulos C
Br J Urol; 1998 Dec; 82(6):829-34. PubMed ID: 9883220
[TBL] [Abstract][Full Text] [Related]
38. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis.
Bergler WF; Götte K
Eur Arch Otorhinolaryngol; 2000; 257(5):263-9. PubMed ID: 10923940
[TBL] [Abstract][Full Text] [Related]
39. Systemic cidofovir in papillomatosis.
Van Valckenborgh I; Wellens W; De Boeck K; Snoeck R; De Clercq E; Feenstra L
Clin Infect Dis; 2001 Feb; 32(3):E62-4. PubMed ID: 11170974
[TBL] [Abstract][Full Text] [Related]
40. Novel treatments for recurrent respiratory papillomatosis.
Armbruster C
Expert Opin Investig Drugs; 2002 Aug; 11(8):1139-48. PubMed ID: 12150707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
